Want to see IN:SHILPAMED full AI Analyst Report?
Shilpa Medicare Limited (SHILPAMED) Stock Forecast & Price Target
SHILPAMED Analyst Ratings
There are no analyst ratings in the last 3 months.
SHILPAMED Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts​
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | INR 955→INR 1,000 | buy | 4.75%Upside | Reiterated | 10/28/26 | ||
| Google General IN | TipRanks - Google | INR 953→INR 998 | buy | 4.54%Upside | Reiterated | 10/28/26 | ||
| Anthropic General IN | TipRanks - Anthropic | INR 915→INR 957 | hold | 0.25%Upside | Reiterated | 10/28/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | INR 919→INR 962 | hold | 0.77%Upside | Reiterated | 10/28/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | INR 949→INR 993 | buy | 4.02%Upside | Reiterated | 10/28/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | INR 962→INR 1,007 | buy | 5.48%Upside | Reiterated | 10/28/26 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 10/28/26 | INR 955→INR 1,000 | buy | 4.75%Upside | Reiterated | TipRanks - PerPlexity | ||
| Google General IN | 10/28/26 | INR 953→INR 998 | buy | 4.54%Upside | Reiterated | TipRanks - Google | ||
| Anthropic General IN | 10/28/26 | INR 915→INR 957 | hold | 0.25%Upside | Reiterated | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 10/28/26 | INR 919→INR 962 | hold | 0.77%Upside | Reiterated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 10/28/26 | INR 949→INR 993 | buy | 4.02%Upside | Reiterated | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 10/28/26 | INR 962→INR 1,007 | buy | 5.48%Upside | Reiterated | TipRanks - xAI |
SHILPAMED Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, SHILPAMED has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SHILPAMED average Analyst price target in the past 3 months is ―.
SHILPAMED Financial Forecast
SHILPAMED Earnings Forecast
Next quarter’s earnings estimate for SHILPAMED is INR 3.90 with a range of INR 3.90 to INR 3.90. The previous quarter’s EPS was INR 5.18. SHILPAMED beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year SHILPAMED has Performed in-line its overall industry.
SHILPAMED Sales Forecast
Next quarter’s sales forecast for SHILPAMED is INR 4.73B with a range of INR 4.70B to INR 4.77B. The previous quarter’s sales results were INR 4.66B. SHILPAMED beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year SHILPAMED has Performed in-line its overall industry.